Hernia mesh devices are surgical implants used to reinforce weakened tissue during hernia repair, available for inguinal, incisional, femoral, and other hernia types. These devices are employed in hospitals, clinics, and ambulatory surgical centers. The market is driven by the high incidence of hernias, with approximately 20 million hernia repair surgeries performed globally each year, of which inguinal hernias account for over 70%. Factors such as obesity, increased abdominal pressure, and aging contribute to demand, with hernia mesh offering a recurrence rate below 5%, making it a preferred solution in both open and minimally invasive procedures.
This product will be delivered within 1-3 business days.
Market Size and Growth Forecast
The global hernia mesh devices market is projected to reach between USD 3.2 billion and USD 5.1 billion in 2025, with a compound annual growth rate (CAGR) of 5.8% to 7.6% through 2030, reflecting the growing surgical burden and technological advancements.Regional Analysis
- North America: The U.S. leads with high laparoscopic surgery adoption, while Canada focuses on hernia care access.
- Europe: Germany, France, and the UK dominate, driven by aging populations and advanced surgical infrastructure.
- Asia Pacific: China and India see rapid growth due to rising obesity rates, while Japan prioritizes elderly hernia solutions.
- Rest of the World: Brazil expands surgical capabilities, and the Middle East, notably the UAE, invests in premium devices.
Application Analysis
- Hospitals & Clinics: Expected growth of 5.5-7.5%, driven by complex repairs. Trends focus on robotic integration.
- Ambulatory Surgical Centers: Projected growth of 6.0-8.0%, linked to outpatient procedures. Developments emphasize efficiency.
- Others: Anticipated growth of 5.2-7.0%, including specialty centers. Advances prioritize patient recovery.
Type Analysis
- Inguinal: Expected growth of 5.8-7.8%, valued for high prevalence. Trends focus on lightweight meshes.
- Incisional: Projected growth of 5.5-7.5%, key for post-surgical repairs. Advances highlight biocompatibility.
- Femoral: Anticipated growth of 5.0-7.0%, suited for specific cases. Developments prioritize durability.
- Others: Expected growth of 5.2-7.2%, including hiatal hernias. Trends emphasize 3D designs.
Key Market Players
Leading firms include BD, offering reliable surgical solutions; Johnson & Johnson, advancing mesh technology; Medtronic, enhancing self-fixating meshes; W. L. Gore & Associates, specializing in biocompatible materials; B. Braun, improving surgical tools; Getinge Group, focusing on infection prevention; Baxter, providing comprehensive devices; Cook, innovating in hernia repair; Herniamesh, targeting lightweight solutions; and Cousin Biotech, enhancing patient outcomes. These companies drive market growth through innovation.Porter's Five Forces Analysis
- Threat of New Entrants: Moderate, due to high R&D costs and regulatory hurdles, though niche players can enter with specialized meshes.
- Threat of Substitutes: Low, as mesh devices are critical for effective hernia repair with few alternatives.
- Bargaining Power of Buyers: Moderate, with hospitals seeking cost-effective, low-complication meshes while balancing surgical needs.
- Bargaining Power of Suppliers: Low, due to multiple material suppliers, reducing dependency risks.
- Competitive Rivalry: High, with firms competing on biocompatibility, recurrence rates, and ease of use.
Market Opportunities and Challenges
Opportunities
- Approximately 20 million annual hernia surgeries globally highlight the need for mesh devices.
- An aging population, projected to reach 2.1 billion over 60 by 2050, increases hernia incidence, with rates up to 40-50% in elderly men.
- The rise of laparoscopic and robotic surgeries, accounting for 25% of U.S. procedures in 2023, boosts adoption.
- Innovations like Gore Bio-A and Medtronic’s ProGrip improve outcomes, while emerging markets offer growth as surgical access expands.
Challenges
- High costs of advanced meshes limit adoption in low-resource regions.
- Complications like chronic pain and infection pose risks.
- Regulatory scrutiny over mesh safety slows market entry.
- Market News
- In January 2024, RTI Surgical acquired Cook Biotech, enhancing its hernia repair portfolio.
- In January 2022, Cook Biotech partnered with the European Hernia Society to advance hernia repair technologies.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Hernia Mesh Devices Market in North America (2020-2030)
Chapter 9 Historical and Forecast Hernia Mesh Devices Market in South America (2020-2030)
Chapter 10 Historical and Forecast Hernia Mesh Devices Market in Asia & Pacific (2020-2030)
Chapter 11 Historical and Forecast Hernia Mesh Devices Market in Europe (2020-2030)
Chapter 12 Historical and Forecast Hernia Mesh Devices Market in MEA (2020-2030)
Chapter 13 Summary For Global Hernia Mesh Devices Market (2020-2025)
Chapter 14 Global Hernia Mesh Devices Market Forecast (2025-2030)
Chapter 15 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- BD
- Johnson & Johnson
- Medtronic
- W. L. Gore & Associates
- B. Braun
- Getinge Group
- Baxter
- Cook
- Herniamesh
- Cousin Biotech